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Preoperative skin antisepsis – it ain’t what you do but the way that you do it. 
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In 2010, the New England Journal of Medicine published a randomized controlled trial (RCT) 
which reported the use of preoperative skin antisepsis using 2% chlorhexidine gluconate/70% 
isopropyl-alcohol (applied with a disposable, purpose-built, sponge applicator and a 
“scrubbing” technique), or an aqueous 10% povidone-iodine based preparation (applied as a 
paint), for prevention of surgical site infection (SSI) 1. Thirty nine of 409 patients in the 2% 
CHG/70% IPA study arm (9.5%) and 71 of 440 patients in the 10% PVP-I study arm (16.1%) 
developed an SSI after clean and clean-contaminated abdominal procedures (RR = 0.59; 95% 
CI: 0.41 – 0.85; P=0.004).  
 
The study led to extensive discussion about the methodology of preoperative skin antisepsis 
and SSI prophylaxis. The limitation of a comparison of aqueous PVP-I with alcoholic CHG in 
particular has been highlighted 2. We agree with this latter observation as it is widely accepted 
that alcoholic chlorhexidine, and not aqueous chlorhexidine solution alone, is superior to 
aqueous povidone-iodine in preventing SSIs in clean and clean-contaminated surgical 
procedures. The clinical effectiveness of CHG, compared with PVP-I skin antisepsis, must be 
determined in equivalent circumstances for formulation (aqueous or alcoholic) and modality 
of application (use of a scrubbing technique using a purpose-built applicator or by a simple 
painting technique). 
 
To strengthen this latter point another similar RCT, also published in the NEJM, adds 
important insight into this conundrum 3. This RCT compared the effect of preoperative skin 
antisepsis using 2% CHG/70% IPA or 8.3% PVP-I/ 72.5% IPA, but using a similar disposable 
applicator for delivery of each antiseptic prior to Caesarean delivery. Twenty three of 572 
(4.0%) patients in the 2% CHG/70% IPA study arm, and 42 of 575 (7.3%) patients in the 
8.3% PVP-I/72.5% IPA study arm developed an SSI (RR = 0.55; 95% CI: 0.34 – 0.90; 
P=0.02). The authors concluded that adding chlorhexidine in alcoholic solution, rather than 
povidone-iodine in alcoholic solution, resulted in a significantly lower risk of SSI after clean 
surgery. 
 
However, in addition to attention to the ingredients of the antiseptic solutions used in the two 
RCTs, aqueous or alcoholic chlorhexidine or povidone-iodine, there is now an opportunity for 
a comparison of the method of application: using either a packaged antiseptic sponge 
applicator or simple painting of the surgical site skin. If the patients who had aqueous 10% 
PVP-I applied as a paint as in the first RCT 1 are compared with those who had 2% CHG/70% 
IPA solution applied with an applicator and scrubbing technique 3, the inferiority to prevent 
SSI using aqueous 10% PVP-I paint is confirmed again (RR = 0.22; 95% CI: 0.13 – 0.36; P< 
0.001). Conversely, if the cohort in the first RCT, who had skin preparation with 2% CHG/ 
70% IPA solution applied with an applicator, is compared with the similar cohort in the Tuuli 
study, who had skin preparation with 8.3% PVP-I/ 72.5% IPA applied with the identical 
applicator, there is no statistical significant difference in the frequency of SSI (RR = 1.34; 
95% CI: 0.83 – 2.16; P=0.26). It is too early to undertake a Forest plot based on only two 
RCTs but when they are combined there is a clear superiority for the use of 2% chlorhexidine 
in alcohol when applied with a sponge applicator.  
 
Although our observation has a number of limitations, including different case-mix and 
surgical procedures, we conclude that not only which antiseptic in alcohol is applied is 
important, but also the way it is applied. Perhaps the use of a disposable, sponge applicator 
enhances delivery of an alcoholic skin preparation, whether it contains chlorhexidine or 
povidone iodine, deeper into the skin appendages, thereby giving a longer exposure to the 
antiseptic and help to reduce bioburden not just on the skin surface.  
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